🟢 Doximity is trading 7.5% up in pre-market as catalyst remains unclear

Doximity is trading at $28.50, up 7.47% in pre-market, with no clear catalyst identified.

• No company announcement or major event found clearly explains the September 30 pre-market jump.
• Evercore ISI maintained its In Line rating and cut its target to $35 from $40 on September 29; the move does not explain the gain.
• The supplied market context is broadly flat, offering no clear market-wide explanation.